PrEP for Your Patients' Needs: The PCP's Role in Preventing HIV

0 reviews

Haymarket Medical Education

1 hour

PROGRAM DESCRIPTION Although HIV incidence in the United States has declined over the last decade, the most recent data from the Centers for Disease Control and Prevention (CDC) identified 37,600 ...

PROGRAM DESCRIPTION
Although HIV incidence in the United States has declined over the last decade, the most recent data from the Centers for Disease Control and Prevention (CDC) identified 37,600 new HIV infections in 2014.1 Moreover, despite the overall gains, certain cohorts remain at particularly high risk of acquiring HIV, including men who have sex with men, heterosexual persons who engage in certain high-risk behaviors, and people who inject drugs.2 As part of a high-impact plan to reduce new HIV infections, the CDC has issued recommendations on the use of pre-exposure prophylaxis (PrEP)—a once-daily, FDA-approved antiretroviral therapy for HIV prophylaxis—as part of a comprehensive approach to reducing the risk of HIV acquisition by individuals in certain identified high-risk populations.3 Many health care providers, however, are unfamiliar with PrEP principles and protocols. This unfamiliarity is often further compounded by clinicians’ misinformation or personal attitudes that negatively affect the management of at-risk individuals.4 Primary care providers (PCPs) are very well-positioned to help close gaps in HIV prevention through guideline-driven testing, risk-reduction counseling, and effective patient education encompassing PrEP initiation and ongoing monitoring.5 In this Interactive ExchangeTM webcast, expert faculty will discuss recent trends in HIV incidence, CDC guidelines for HIV testing and identification of individuals at substantial risk, and protocols for determination of PrEP eligibility and longitudinal on-PrEP monitoring. The goal is to offer PCPs the tools they need to effectively provide HIV-prevention services. References:1. CDC Fact Sheet. HIV Incidence: Estimated Annual Infections in the U.S., 2008-2014. 2017. Accessed December 14, 2017.2. CDC. Surveillance Overview. Last updated January 2017. https://www.cdc.gov/hi.... Accessed December 14, 2017.3. US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States−2014: A Clinical Practice Guideline. www.cdc.gov/hiv/pdf/gu.... Accessed December 14, 2017.4. Smith DK, et al. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS One. 2016;11(6):e0156592.5. Conniff J, Evensen A. Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective. J Am Board Fam Med. 2016;29(1):143-151.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:Demonstrate actionable knowledge of PrEP needs, principles, and goals, and fully implement the 2014 US Public Health Service (USPHS)/Centers for Disease Control and Prevention (CDC) clinical practice guideline: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014Create open patient-provider dialogue and engage the patient as an active, educated participant in clinical decision-making and ongoing patient-centric monitoringProvide proactive universal HIV-risk screening, establish substantial risk for HIV acquisition, determine PrEP eligibility, and assess patients’ PrEP readiness, preferences, and barriers to sustained adherenceCounsel patients regarding PrEP efficacy and safety; provide ongoing guideline-based clinical and laboratory monitoring, risk-reduction strategies, and treatment-adherence counseling to patients receiving PrEP